2XVW - JenaLib

Asymmetric/Biological Unit (58, 58)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_000505	H	27	Q	ALBU_HUMAN	Polymorphism	76285851	A	H	3	Q
02	UniProt	VAR_000506	H	27	Y	ALBU_HUMAN	Polymorphism	141733599	A	H	3	Y
03	UniProt	VAR_010657	F	73	Y	ALBU_HUMAN	Polymorphism	---	A	F	49	Y
04	UniProt	VAR_000507	E	84	K	ALBU_HUMAN	Polymorphism	77050410	A	E	60	K
05	UniProt	VAR_000508	D	87	N	ALBU_HUMAN	Polymorphism	78574148	A	D	63	N
06	UniProt	VAR_013011	L	90	P	ALBU_HUMAN	Disease (FDAH)	77892378	A	L	66	P
07	UniProt	VAR_000509	E	106	K	ALBU_HUMAN	Polymorphism	80296402	A	E	82	K
08	UniProt	VAR_014290	E	121	G	ALBU_HUMAN	Polymorphism	---	A	E	97	G
09	UniProt	VAR_000510	R	138	G	ALBU_HUMAN	Polymorphism	77238412	A	R	114	G
10	UniProt	VAR_000511	E	143	K	ALBU_HUMAN	Polymorphism	75522063	A	E	119	K
11	UniProt	VAR_013012	V	146	E	ALBU_HUMAN	Polymorphism	77752336	A	V	122	E
12	UniProt	VAR_000512	H	152	R	ALBU_HUMAN	Polymorphism	80095457	A	H	128	R
13	UniProt	VAR_000513	C	201	F	ALBU_HUMAN	Polymorphism	77656691	A	C	177	F
14	UniProt	VAR_014291	A	215	T	ALBU_HUMAN	Polymorphism	3210154	A	A	191	T
15	UniProt	VAR_014292	A	215	V	ALBU_HUMAN	Polymorphism	3204504	A	A	191	V
16	UniProt	VAR_014293	Q	220	L	ALBU_HUMAN	Polymorphism	3210163	A	Q	196	L
17	UniProt	VAR_000514	R	242	H	ALBU_HUMAN	Disease (FDAH)	75002628	A	R	218	H
18	UniProt	VAR_013013	R	242	P	ALBU_HUMAN	Disease (FDAH)	75002628	A	R	218	P
19	UniProt	VAR_000515	K	249	Q	ALBU_HUMAN	Polymorphism	79804069	A	K	225	Q
20	UniProt	VAR_000516	K	264	E	ALBU_HUMAN	Polymorphism	79377490	A	K	240	E
21	UniProt	VAR_000517	Q	292	R	ALBU_HUMAN	Polymorphism	80002911	A	Q	268	R
22	UniProt	VAR_000518	D	293	G	ALBU_HUMAN	Polymorphism	79744198	A	D	269	G
23	UniProt	VAR_000519	K	300	N	ALBU_HUMAN	Polymorphism	74718349	A	K	276	N
24	UniProt	VAR_000520	K	337	N	ALBU_HUMAN	Polymorphism	72552710	A	K	313	N
25	UniProt	VAR_013014	D	338	G	ALBU_HUMAN	Polymorphism	76242087	A	D	314	G
26	UniProt	VAR_013015	D	338	V	ALBU_HUMAN	Polymorphism	76242087	A	D	314	V
27	UniProt	VAR_000521	N	342	K	ALBU_HUMAN	Polymorphism	77544362	A	N	318	K
28	UniProt	VAR_000522	A	344	T	ALBU_HUMAN	Polymorphism	78953271	A	A	320	T
29	UniProt	VAR_000523	E	345	K	ALBU_HUMAN	Polymorphism	72552711	A	E	321	K
30	UniProt	VAR_000524	E	357	K	ALBU_HUMAN	Polymorphism	77354753	A	E	333	K
31	UniProt	VAR_000525	E	378	K	ALBU_HUMAN	Polymorphism	76593094	A	E	354	K
32	UniProt	VAR_000526	E	382	K	ALBU_HUMAN	Polymorphism	75791663	A	E	358	K
33	UniProt	VAR_013016	K	383	N	ALBU_HUMAN	Polymorphism	75069738	A	K	359	N
34	UniProt	VAR_000527	D	389	H	ALBU_HUMAN	Polymorphism	77187142	A	D	365	H
35	UniProt	VAR_000528	D	389	V	ALBU_HUMAN	Polymorphism	78538497	A	D	365	V
36	UniProt	VAR_000529	K	396	E	ALBU_HUMAN	Polymorphism	78166690	A	K	372	E
37	UniProt	VAR_000530	D	399	N	ALBU_HUMAN	Polymorphism	77514449	A	D	375	N
38	UniProt	VAR_000531	E	400	K	ALBU_HUMAN	Polymorphism	79047363	A	E	376	K
39	UniProt	VAR_000532	E	400	Q	ALBU_HUMAN	Polymorphism	79047363	A	E	376	Q
40	UniProt	VAR_000533	E	406	K	ALBU_HUMAN	Polymorphism	76483862	A	E	382	K
41	UniProt	VAR_014294	E	420	K	ALBU_HUMAN	Polymorphism	---	A	E	396	K
42	UniProt	VAR_013017	R	434	C	ALBU_HUMAN	Polymorphism	78575701	A	R	410	C
43	UniProt	VAR_014295	K	490	E	ALBU_HUMAN	Polymorphism	1063469	A	K	466	E
44	UniProt	VAR_000534	E	503	K	ALBU_HUMAN	Polymorphism	80259813	A	E	479	K
45	UniProt	VAR_000535	D	518	N	ALBU_HUMAN	Polymorphism	75920790	A	D	494	N
46	UniProt	VAR_000536	E	525	K	ALBU_HUMAN	Polymorphism	75523493	A	E	501	K
47	UniProt	VAR_000537	E	529	K	ALBU_HUMAN	Polymorphism	74826639	A	E	505	K
48	UniProt	VAR_013018	V	557	M	ALBU_HUMAN	Polymorphism	78284052	A	V	533	M
49	UniProt	VAR_000538	K	560	E	ALBU_HUMAN	Polymorphism	77645174	A	K	536	E
50	UniProt	VAR_000539	K	565	E	ALBU_HUMAN	Polymorphism	80345158	A	K	541	E
51	UniProt	VAR_000541	D	574	A	ALBU_HUMAN	Polymorphism	79738788	A	D	550	A
52	UniProt	VAR_000540	D	574	G	ALBU_HUMAN	Polymorphism	79738788	A	D	550	G
53	UniProt	VAR_013019	K	584	E	ALBU_HUMAN	Polymorphism	76671808	A	K	560	E
54	UniProt	VAR_000542	D	587	N	ALBU_HUMAN	Polymorphism	76587671	A	D	563	N
55	UniProt	VAR_000543	E	589	K	ALBU_HUMAN	Polymorphism	75709682	A	E	565	K
56	UniProt	VAR_000544	E	594	K	ALBU_HUMAN	Polymorphism	79228041	A	E	570	K
57	UniProt	VAR_000545	K	597	E	ALBU_HUMAN	Polymorphism	80106970	A	K	573	E
58	UniProt	VAR_000546	K	598	N	ALBU_HUMAN	Polymorphism	75738598	A	K	574	N

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (2, 5)

Exons (14, 14)

Sequences/Alignments

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:582
 aligned with ALBU_HUMAN | P02768 from UniProtKB/Swiss-Prot  Length:609

    Alignment length:582
                                    36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486       496       506       516       526       536       546       556       566       576       586       596       606  
           ALBU_HUMAN    27 HKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALG 608
               SCOP domains d2xvwa1 A:3-196 automated matches                                                                                                                                                                 d2xvwa2 A:197-388 automated matches                                                                                                                                                             d2xvwa3 A:389-584 automated matches                                                                                                                                                                  SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
           Pfam domains (1) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Serum_albumin-2xvwA01 A:388-568                                                                                                                                                      ---------------- Pfam domains (1)
           Pfam domains (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Serum_albumin-2xvwA02 A:388-568                                                                                                                                                      ---------------- Pfam domains (2)
           Pfam domains (3) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Serum_albumin-2xvwA03 A:388-568                                                                                                                                                      ---------------- Pfam domains (3)
         Sec.struct. author ..hhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhhh........hhhhhhhhhhh...hhhhhhhhhhhhhhh..hhhhhhhhhh.............hhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhh...........hhhhhh...hhhhhhhhhhhhhhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhh...hhhhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhh...hhhhhhhh.............hhhhh..hhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhh. Sec.struct. author
             SAPs(SNPs) (1) Q---------------------------------------------Y----------K--N--P---------------K--------------G----------------G----K--E-----R------------------------------------------------F-------------T----L---------------------H------Q--------------E---------------------------RG------N------------------------------------NG---K-TK-----------K--------------------K---KN-----H------E--NK-----K-------------K-------------C-------------------------------------------------------E------------K--------------N------K---K---------------------------M--E----E--------A---------E--N-K----K--EN---------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) Y-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------V--------------------------P-----------------------------------------------------------------------------------------------V--------------------------------------------------V----------Q-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------G---------------------------------- SAPs(SNPs) (2)
                PROSITE (1) ALBUMIN_2  PDB: - UniProt: 19-210                                                                                                                                                       ALBUMIN_2  PDB: A:187-379 UniProt: 211-403                                                                                                                                                       ALBUMIN_2  PDB: A:380-577 UniProt: 404-601                                                                                                                                                            ------- PROSITE (1)
                PROSITE (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:161-185-----------------------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:353-377-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------ALBUMIN_1  PDB: A:551-575--------- PROSITE (2)
           Transcript 1 (1) 1------------------Exon 1.4b  PDB: A:22-66 UniProt: 46-90       Exon 1.5a  PDB: A:67-137 UniProt: 91-161                               --------------------------------------------Exon 1.8a  PDB: A:182-214        -------------------------------------------Exon 1.10b  PDB: A:258-329 UniProt: 282-353                             --------------------------------------------Exon 1.12  PDB: A:374-406        ----------------------------------------------Exon 1.14b  PDB: A:453-527 UniProt: 477-551                                --------------------------------------------Exon 1.18a    Transcript 1 (1)
           Transcript 1 (2) Exon 1.3a           ------------------------------------------------------------------------------------------------------------------Exon 1.7d  PDB: A:137-181 UniProt: 161-205   --------------------------------Exon 1.9a  PDB: A:214-257 UniProt: 238-281  -----------------------------------------------------------------------Exon 1.11a  PDB: A:329-373 UniProt: 353-397  --------------------------------Exon 1.13b  PDB: A:406-452 UniProt: 430-476    --------------------------------------------------------------------------Exon 1.16b  PDB: A:527-571 UniProt: 551-595  ------------- Transcript 1 (2)
                 2xvw A   3 HKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKEEQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALG 584
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492       502       512       522       532       542       552       562       572       582

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 3)

CATH Domains (0, 0)

Pfam Domains (1, 3)

Gene Ontology (45, 45)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (ALBU_HUMAN | P02768)

molecular function
	GO:0003677	DNA binding	Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
	GO:0016209	antioxidant activity	Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage.
	GO:0051087	chaperone binding	Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
	GO:0005507	copper ion binding	Interacting selectively and non-covalently with copper (Cu) ions.
	GO:0008144	drug binding	Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0005504	fatty acid binding	Interacting selectively and non-covalently with fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
	GO:0008289	lipid binding	Interacting selectively and non-covalently with a lipid.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0019825	oxygen binding	Interacting selectively and non-covalently with oxygen (O2).
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0030170	pyridoxal phosphate binding	Interacting selectively and non-covalently with pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.
	GO:0015643	toxic substance binding	Interacting selectively and non-covalently with a toxic substance, a poisonous substance that causes damage to biological systems.
	GO:0008270	zinc ion binding	Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
	GO:0015721	bile acid and bile salt transport	The directed movement of bile acid and bile salts into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
	GO:0098869	cellular oxidant detoxification	Any process carried out at the cellular level that reduces or removes the toxicity superoxide radicals or hydrogen peroxide.
	GO:0009267	cellular response to starvation	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
	GO:0019836	hemolysis by symbiont of host erythrocytes	The cytolytic destruction of red blood cells, with the release of intracellular hemoglobin, in the host organism by a symbiont. The host is defined as the larger of the organisms involved in a symbiotic interaction.
	GO:0042157	lipoprotein metabolic process	The chemical reactions and pathways involving any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
	GO:0051659	maintenance of mitochondrion location	Any process in which a mitochondrion is maintained in a specific location within a cell and prevented from moving elsewhere.
	GO:0043066	negative regulation of apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
	GO:0043069	negative regulation of programmed cell death	Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes.
	GO:0002576	platelet degranulation	The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
	GO:0046010	positive regulation of circadian sleep/wake cycle, non-REM sleep	Any process that activates or increases the duration or quality of non-rapid eye movement (NREM) sleep.
	GO:0006898	receptor-mediated endocytosis	An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
	GO:0046689	response to mercury ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mercury ion stimulus.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
	GO:0010033	response to organic substance	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
	GO:0070541	response to platinum ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platinum stimulus.
	GO:0001895	retina homeostasis	A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
	GO:0043252	sodium-independent organic anion transport	The directed, sodium-independent, movement of organic anions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
	GO:0006810	transport	The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.
cellular component
	GO:0005794	Golgi apparatus	A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
	GO:0005604	basement membrane	A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005783	endoplasmic reticulum	The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0043209	myelin sheath	An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0031093	platelet alpha granule lumen	The volume enclosed by the membrane of the platelet alpha granule.
	GO:0043234	protein complex	A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File

1ao6	CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1bj5	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
1bke	HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI-IODOBENZOIC ACID
1bm0	CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1e78	CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
1e7a	CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
1e7b	CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH HALOTHANE
1e7c	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE
1e7e	HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID
1e7f	HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID
1e7g	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
1e7h	HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID
1e7i	HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID
1gni	HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9- OCTADECENOIC ACID (OLEIC ACID)
1gnj	HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8 ,11,14-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)
1h9z	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN
1ha2	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S-(-) ENANTIOMER OF WARFARIN
1hk1	HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
1hk2	HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
1hk3	HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE)
1hk4	HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
1hk5	HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
1n5u	X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME
1o9x	HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN
1tf0	CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMANSERUM ALBUMIN
1uor	X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN
1ysx	SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMINCOMPLEXED TO AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL-XL AND BCL-2
2bx8	HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
2bxa	HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY -4-METHYL-5-PROPYL-2-FURANPROPANOIC ACID (CMPF)
2bxb	HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
2bxc	HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
2bxd	HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
2bxe	HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
2bxf	HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
2bxg	HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
2bxh	HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
2bxi	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE
2bxk	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, AZAPROPAZONE AND INDOMETHACIN
2bxl	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 3,5-DIIODOSALICYLIC ACID
2bxm	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN
2bxn	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE
2bxo	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE
2bxp	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE
2bxq	HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE, PHENYLBUTAZONE AND INDOMETHACIN
2esg	SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULINIGA1 AND HUMAN SERUM ALBUMIN
2vdb	STRUCTURE OF HUMAN SERUM ALBUMIN WITH S- NAPROXEN AND THE GA MODULE
2vue	HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z,15E- BILIRUBIN-IX-ALPHA
2vuf	HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
2xvq	HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L -SARCOSINE
2xvu	HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L -ASPARAGINE
2xvv	HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L -ASPARAGINE AND MYRISTIC ACID

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 8)

Sites (7, 7)

SS Bonds (17, 17)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (58, 58)